Cain Wettan Keeley M sold 3,399 shares of GILEAD SCIENCES, INC. at $164.11 for −$558k on Nov 6, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
EVP Gen Counsel, Legal & Comp
EVP Gen Counsel, Legal & Comp
Filed Nov 9, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$557,809.89Shares × reported price
Shares traded
3,399Common Stock
Price per share
$164.11Reported price. Read footnotes for ranges.
% of reported position traded
38.81%This security and ownership context
Holdings after
5,360Direct
Trade date
Nov 6, 2026Sell
Filed
Nov 9, 2026, 7:20 PM ET4-day reporting delay
Accession
0002110603-26-000015Code S · Transaction 396493
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 8,759 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

GILD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
GILD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 17, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −13%1w ago +0.8%1d ago −1%
Returns since7d30d90d180d1y

Footnotes in full

F1: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 07, 2026.